Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: 5 | History Defined

NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump

UK ministers preparing to raise payments to end standoff with pharma industry, cited as reason for firms axing British investments

The Guardian - UK

Why AbbVie and Johnson & Johnson Could Outperform Pfizer

Why AbbVie and Johnson & Johnson Could Outperform Pfizer

Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential

TrumpRx Brings Pfizer Into the Green—Is It a Buy?

TrumpRx Brings Pfizer Into the Green—Is It a Buy?

Pfizer entered into a major agreement with the U.S. government to produce more affordable drugs for Americans. However, the stock’s outlook is still cloudy.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal

Eli Lilly just got great news, courtesy of Pfizer and Trump, leading shares to their highest level in five months. Its rally may just be getting started.

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants

Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief.

Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets

Wall Street soared to fresh record highs at the end of the week, brushing aside the 21st U.S. government shutdown in history and a missing jobs report, as investors doubled down on bets for interest rate cuts and cheered strong gains in pharmaceutical and AI-driven tech stocks.

These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap

Health care stocks are on track for their best week in years, yet even after the rally, several pharma giants remain absurdly cheap by market standards.

inkl

Read news from The Economist, FT, and more,
with one subscription

TrumpRx Is Obamacare in Trump's Handwriting

Pfizer wins big in Trump’s new drug discount gimmick.

Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’

Mark Cuban says Trump’s new drug platform could succeed if it forces pharma managers to change: ‘If that happens, Trump gets all the credit’

Cuban’s Cost Plus Drugs, which he founded in 2022, similarly provides direct-to-consumer discounted pharmaceuticals.

Top 3 Dividend Achievers for October: High Yields, Growth Ahead

Top 3 Dividend Achievers for October: High Yields, Growth Ahead

High-yield Dividend Achievers, such as United Parcel Service, Verizon, and Pfizer, offer attractive entry points in October for income investors.

Stocks Rally as Weak US Jobs News Reinforces Fed Rate Cut Hopes

Stocks Rally as Weak US Jobs News Reinforces Fed Rate Cut Hopes

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.49%. December E-mini S&P futures (ESZ25 ) rose +0.30%, and December E-mini Nasdaq futures...

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years

Investors cheered a breakthrough drug pricing agreement between President Donald Trump and Pfizer Inc. (NYSE:PFE), sparking a sector-wide surge in health care stocks that delivered the biggest rally in five years.

Inside the TrumpRx website and its unusual launch

Trump has been urging prescription drug manufacturers to lower U.S. prices.

Pfizer Shares Are Trading Higher Wednesday: What's Going On?

Pfizer (NYSE:PFE) shares are trading higher Wednesday after President Donald Trump announced a drug-pricing deal with the company.

Get all your
news in one place.

100's of premium titles.
One news app.

Eli Lilly Shares Are Trading Higher Wednesday: What's Going On?

Eli Lilly And Company (NYSE:LLY) shares are trading higher Wednesday after President Donald Trump recently announced a deal with Pfizer as well as the ‘TrumpRx’ site to decrease prices.

Moderna Stock Is Rallying Wednesday: What's Driving The Action?

Moderna Inc (NASDAQ:MRNA) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc (NYSE:PFE) and the Trump administration to lower prescription drug prices.

Evening Standard

FTSE 100 hits another high despite concerns over US government shutdown

Drug companies AstraZeneca, Hikma Pharmaceuticals and GSK were all big risers.

The Independent UK

How TrumpRx will work — and why insured Americans may not save any money

Pfizer will now sell drugs to Medicaid at ‘most-favored-nation’ prices, the White House announced

Get all your
news in one place.

100's of premium titles.
One news app.

Stock Of The Day: Will Pfizer Head Higher?

Shares of Pfizer Inc. (NYSE:PFE) continue to head higher on Wednesday, a day after the company announced that it has secured a three-year grace period from President Donald Trump's tariffs on pharmaceuticals. This will enable Pfizer to offer its medication at significantly discounted prices compared to current rates.

Stocks Trim Losses as Drug Makers Rally

The S&P 500 Index ($SPX ) (SPY ) today is down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.02%. December E-mini S&P futures (ESZ25 ) are down -0.05%, and December E-mini Nasdaq futures...

Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away

Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new TrumpRx platform at steep discounts and extend "most favored nation" (MFN) pricing to Medicaid, Pfizer bought itself a…

Mark Cuban Grades Trump's Online Drug Store 'B,' Plans To Give It An 'A' If These Changes Happen: 'Trump Gets All The Credit'

Mark Cuban, the billionaire entrepreneur and investor, has given a cautious “B” grade to President Donald Trump’s new online drug store venture, TrumpRx.gov.

International Business Times UK

Laughter In The Oval Office As Trump Cracks COVID Joke Over Secretary Kennedy's Sneeze

Donald Trump sparked laughter in the Oval Office after cracking a COVID-19 joke when Secretary Kennedy sneezed during a meeting. The remark has drawn both chuckles and criticism online.

International Business Times UK

'TrumpRx': President Unveils New Drug Price-Cutting Website As Pfizer Agrees To Slash Costs By 50%

Trump announced a website for consumers to buy medicines at heavily discounted prices. He also forged a deal with Pfizer, where the drugmaker will slash prices for several of its products.

S&P Futures Slip on U.S. Government Shutdown, ADP Jobs Report in Focus

December S&P 500 E-Mini futures (ESZ25) are trending down -0.56% this morning as sentiment took a hit after the U.S. government shut down for the first time in seven years.

1 … 4 5 6 7

People

181,903 stories

Robert F. Kennedy Jr

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the White House

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Government Shutdown

Prescription Drug

Places

362,797 stories

136,527 stories

Washington D.C.

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play